• SPX
  • $5,953.03
  • 0.61 %
  • $35.92
  • DJI
  • $43,958.55
  • 1.27 %
  • $550.07
  • N225
  • $38,026.17
  • -0.85 %
  • -$326.17
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,979.46
  • 0.07 %
  • $13.32
Enfusion, Inc. (ENFN) Stock Price, News & Analysis

Enfusion, Inc. (ENFN) Stock Price, News & Analysis

Currency in USD Disclaimer

$10.09

$0.2

(2.02%)

Day's range
$9.91
Day's range
$10.18
50-day range
$8.07
Day's range
$10.18
  • Country: US
  • ISIN: US2928121043
52 wk range
$7.52
Day's range
$10.45


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score 14.85
  • Piotroski Score 6.00
  • Grade Underperform
  • Symbol (ENFN)
  • Company Enfusion, Inc.
  • Price $10.09
  • Changes Percentage (2.02%)
  • Change $0.2
  • Day Low $9.91
  • Day High $10.18
  • Year High $10.45

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/11/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Neutral
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) $0.02
  • Trailing P/E Ratio 431
  • Forward P/E Ratio 431
  • P/E Growth 431
  • Net Income $6.03 M

Income Statement

Quarterly

Annual

Latest News of ENFN

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Enfusion, Inc. Frequently Asked Questions

  • What is the Enfusion, Inc. stock price today?

    Today's price of Enfusion, Inc. is $10.09 — it has increased by +2.02% in the past 24 hours. Watch Enfusion, Inc. stock price performance more closely on the chart.

  • Does Enfusion, Inc. release reports?

    Yes, you can track Enfusion, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Enfusion, Inc. stock forecast?

    Watch the Enfusion, Inc. chart and read a more detailed Enfusion, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Enfusion, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NYSE, exchange stock trades by Enfusion, Inc. stock ticker.

  • How to buy Enfusion, Inc. stocks?

    Like other stocks, ENFN shares are sold on stock exchanges such as NYSE. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Enfusion, Inc.'s EBITDA?

    Enfusion, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Enfusion, Inc.’s financial statements.

  • What is the Enfusion, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is 0.0345202968, which equates to approximately 3.45%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Enfusion, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Enfusion, Inc.'s financials relevant news, and technical analysis. Enfusion, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Enfusion, Inc. stock currently indicates a “sell” signal. For more insights, review Enfusion, Inc.’s technical analysis.

  • A revenue figure for Enfusion, Inc. for its last quarter?

    Enfusion, Inc. published it's last quarterly revenues at $51.17 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.